Literature DB >> 34716819

Serum progesterone level above 0.85 ng/mL and progesterone/estradiol ratio may be useful predictors for replacing cleavage-stage with blastocyst-stage embryo transfer in fresh IVF/ICSI cycles without premature progesterone elevation.

Vehbi Yavuz Tokgoz1, Ahmet Basar Tekin2.   

Abstract

PURPOSE: To assess the impact of serum progesterone level and the progesterone/estradiol ratio on determining the appropriate day of embryo transfer in fresh IVF/ICSI cycles without premature progesterone elevation.
METHODS: This was a retrospective cohort study in a university teaching hospital. Only fresh embryo transfer cycles in the GnRH-antagonist protocol without elevated trigger-day progesterone levels (n = 508) were analyzed after taking into consideration the exclusion criteria. The main outcome measure was to determine the association between below and above of the cut-off values of serum progesterone level and P/E2 ratio regarding clinical pregnancy, ongoing pregnancy and live birth rates. These rates were assessed with the use of percentile and logistic regression analyses according to the threshold levels of serum progesterone levels < 0.85 ng/mL versus ≥ 0.85 ng/mL on the day of hCG administration.
RESULTS: The clinical pregnancy rates were significantly lower in fresh cycles with P levels ≥ 0.85 ng/mL on the day of hCG administration than in cycles with P levels < 0.85 ng/mL for the cleavage-stage embryo transfers (26.7% vs. 47.5%, p = 0.001). Blastocyst-stage embryo transfer improved pregnancy results although the P levels were ≥ 0.85 ng/mL (53.8% vs. 51.4%, p > 0.05). The adjusted odds ratio of P levels < 0.85 ng/mL revealed significant differences in only cleavage-stage embryo transfer cycles (aOR = 0.424, p = 0.016).
CONCLUSION: Although serum progesterone levels are below the accepted cut-off level of 1.5 ng/mL, there may be reduced pregnancy outcomes in fresh embryo transfer cycles. A threshold level such as 0.85 ng/mL may ensure the decision to replace the cleavage stage with the blastocyst-stage embryo transfer in fresh cycles without premature progesterone elevation.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Fresh embryo transfer; GnRH antagonist; IVF; Pregnancy rate; Progesterone

Mesh:

Substances:

Year:  2021        PMID: 34716819     DOI: 10.1007/s00404-021-06304-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  33 in total

1.  Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles.

Authors:  E Bosch; E Labarta; J Crespo; C Simón; J Remohí; J Jenkins; A Pellicer
Journal:  Hum Reprod       Date:  2010-06-10       Impact factor: 6.918

2.  Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression.

Authors:  I Van Vaerenbergh; H M Fatemi; C Blockeel; L Van Lommel; P In't Veld; F Schuit; E M Kolibianakis; P Devroey; C Bourgain
Journal:  Reprod Biomed Online       Date:  2010-11-13       Impact factor: 3.828

3.  Progesterone level at oocyte retrieval predicts in vitro fertilization success in a short-antagonist protocol: a prospective cohort study.

Authors:  Shweta Nayak; Melanie E Ochalski; Bo Fu; Kathryn-Mary Wakim; Tian Jao Chu; Xinxin Dong; Anthony N Wakim
Journal:  Fertil Steril       Date:  2013-12-17       Impact factor: 7.329

4.  Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles.

Authors:  C A Venetis; E M Kolibianakis; J K Bosdou; B C Tarlatzis
Journal:  Hum Reprod Update       Date:  2013-07-04       Impact factor: 15.610

5.  Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers.

Authors:  Robert Ochsenkühn; Andrea Arzberger; Viktoria von Schönfeldt; Julia Gallwas; Nina Rogenhofer; Alexander Crispin; Christian J Thaler; Ulrich Noss
Journal:  Fertil Steril       Date:  2012-05-24       Impact factor: 7.329

6.  Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.

Authors:  Ze Wu; Rong Li; Yanping Ma; Bo Deng; Xiaomei Zhang; Yushi Meng; Xinna Chen; Ping Liu; Jie Qiao
Journal:  Reprod Biomed Online       Date:  2012-02-14       Impact factor: 3.828

7.  Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.

Authors:  Bei Xu; Zhou Li; Hanwang Zhang; Lei Jin; Yufeng Li; Jihui Ai; Guijin Zhu
Journal:  Fertil Steril       Date:  2012-04-10       Impact factor: 7.329

8.  An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol.

Authors:  Tsung-Hsuan Lai; Fa-Kung Lee; Tseng-Kai Lin; Shang-Gwo Horng; Su-Chee Chen; Ya-Hui Chen; Pa-Chun Wang
Journal:  Fertil Steril       Date:  2008-08-12       Impact factor: 7.329

9.  Serum progesterone concentration on day of HCG administration and IVF outcome.

Authors:  R Li; J Qiao; L Wang; X Zhen; Y Lu
Journal:  Reprod Biomed Online       Date:  2008-05       Impact factor: 3.828

10.  Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials.

Authors:  Georg Griesinger; Bernadette Mannaerts; Claus Yding Andersen; Han Witjes; Efstratios M Kolibianakis; Keith Gordon
Journal:  Fertil Steril       Date:  2013-09-29       Impact factor: 7.329

View more
  1 in total

1.  Effect of serum progesterone levels on hCG trigger day on pregnancy outcomes in GnRH antagonist cycles.

Authors:  Junwei Zhang; Mingze Du; Yanli Wu; Zhancai Wei; Yichun Guan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-28       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.